These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 31496136)
61. Effects of Maternal Choline Supplementation on the Septohippocampal Cholinergic System in the Ts65Dn Mouse Model of Down Syndrome. Kelley CM; Ash JA; Powers BE; Velazquez R; Alldred MJ; Ikonomovic MD; Ginsberg SD; Strupp BJ; Mufson EJ Curr Alzheimer Res; 2016; 13(1):84-96. PubMed ID: 26391045 [TBL] [Abstract][Full Text] [Related]
62. App gene dosage modulates endosomal abnormalities of Alzheimer's disease in a segmental trisomy 16 mouse model of down syndrome. Cataldo AM; Petanceska S; Peterhoff CM; Terio NB; Epstein CJ; Villar A; Carlson EJ; Staufenbiel M; Nixon RA J Neurosci; 2003 Jul; 23(17):6788-92. PubMed ID: 12890772 [TBL] [Abstract][Full Text] [Related]
63. Acute injections of the NMDA receptor antagonist memantine rescue performance deficits of the Ts65Dn mouse model of Down syndrome on a fear conditioning test. Costa AC; Scott-McKean JJ; Stasko MR Neuropsychopharmacology; 2008 Jun; 33(7):1624-32. PubMed ID: 17700645 [TBL] [Abstract][Full Text] [Related]
64. Automation of analysis of cardiovascular autonomic function from chronic measurements of arterial pressure in conscious rats. Waki H; Katahira K; Polson JW; Kasparov S; Murphy D; Paton JF Exp Physiol; 2006 Jan; 91(1):201-13. PubMed ID: 16239254 [TBL] [Abstract][Full Text] [Related]
65. Morphological alterations in the hippocampus of the Ts65Dn mouse model for Down Syndrome correlate with structural plasticity markers. Villarroya O; Ballestín R; López-Hidalgo R; Mulet M; Blasco-Ibáñez JM; Crespo C; Nacher J; Gilabert-Juan J; Varea E Histol Histopathol; 2018 Jan; 33(1):101-115. PubMed ID: 28374408 [TBL] [Abstract][Full Text] [Related]
66. Arterial Pressure, Heart Rate, and Cerebral Hemodynamics Across the Adult Life Span. Xing CY; Tarumi T; Meijers RL; Turner M; Repshas J; Xiong L; Ding K; Vongpatanasin W; Yuan LJ; Zhang R Hypertension; 2017 Apr; 69(4):712-720. PubMed ID: 28193707 [TBL] [Abstract][Full Text] [Related]
67. Dentate gyrus mediates cognitive function in the Ts65Dn/DnJ mouse model of Down syndrome. Smith GK; Kesner RP; Korenberg JR Hippocampus; 2014 Mar; 24(3):354-62. PubMed ID: 24339224 [TBL] [Abstract][Full Text] [Related]
68. Pharmacotherapy with fluoxetine restores functional connectivity from the dentate gyrus to field CA3 in the Ts65Dn mouse model of down syndrome. Stagni F; Magistretti J; Guidi S; Ciani E; Mangano C; Calzà L; Bartesaghi R PLoS One; 2013; 8(4):e61689. PubMed ID: 23620781 [TBL] [Abstract][Full Text] [Related]
69. Highly penetrant myeloproliferative disease in the Ts65Dn mouse model of Down syndrome. Kirsammer G; Jilani S; Liu H; Davis E; Gurbuxani S; Le Beau MM; Crispino JD Blood; 2008 Jan; 111(2):767-75. PubMed ID: 17901249 [TBL] [Abstract][Full Text] [Related]
70. Longitudinal studies on the effect of hypertension on circadian hemodynamic and autonomic rhythms in telemetered rats. El-Mas MM; Abdel-Rahman AA Life Sci; 2005 Jan; 76(8):901-15. PubMed ID: 15589967 [TBL] [Abstract][Full Text] [Related]
71. Comprehensive behavioral phenotyping of Ts65Dn mouse model of Down syndrome: activation of β1-adrenergic receptor by xamoterol as a potential cognitive enhancer. Faizi M; Bader PL; Tun C; Encarnacion A; Kleschevnikov A; Belichenko P; Saw N; Priestley M; Tsien RW; Mobley WC; Shamloo M Neurobiol Dis; 2011 Aug; 43(2):397-413. PubMed ID: 21527343 [TBL] [Abstract][Full Text] [Related]
72. Hematopoietic Stem Cells from Ts65Dn Mice Are Deficient in the Repair of DNA Double-Strand Breaks. Wang Y; Chang J; Shao L; Feng W; Luo Y; Chow M; Du W; Meng A; Zhou D Radiat Res; 2016 Jun; 185(6):630-7. PubMed ID: 27243896 [TBL] [Abstract][Full Text] [Related]
73. Behavioral validation of the Ts65Dn mouse model for Down syndrome of a genetic background free of the retinal degeneration mutation Pde6b(rd1). Costa AC; Stasko MR; Schmidt C; Davisson MT Behav Brain Res; 2010 Jan; 206(1):52-62. PubMed ID: 19720087 [TBL] [Abstract][Full Text] [Related]
74. Increased incidence of intermittent hypoxemia in the Ts65Dn mouse model of Down syndrome. Das D; Medina B; Baktir MA; Mojabi FS; Fahimi A; Ponnusamy R; Salehi A Neurosci Lett; 2015 Sep; 604():91-6. PubMed ID: 26240993 [TBL] [Abstract][Full Text] [Related]
75. Three-dimensional synaptic ultrastructure in the dentate gyrus and hippocampal area CA3 in the Ts65Dn mouse model of Down syndrome. Popov VI; Kleschevnikov AM; Klimenko OA; Stewart MG; Belichenko PV J Comp Neurol; 2011 May; 519(7):1338-54. PubMed ID: 21452200 [TBL] [Abstract][Full Text] [Related]
76. Altered astrocyte calcium homeostasis and proliferation in theTs65Dn mouse, a model of Down syndrome. Bambrick LL; Yarowsky PJ; Krueger BK J Neurosci Res; 2003 Jul; 73(1):89-94. PubMed ID: 12815712 [TBL] [Abstract][Full Text] [Related]
77. Defective thymic progenitor development and mature T-cell responses in a mouse model for Down syndrome. Lorenzo LP; Shatynski KE; Clark S; Yarowsky PJ; Williams MS Immunology; 2013 Aug; 139(4):447-58. PubMed ID: 23432468 [TBL] [Abstract][Full Text] [Related]
78. Orthostatic Blood Pressure Changes and Subclinical Markers of Atherosclerosis. Takahashi M; Miyai N; Nagano S; Utsumi M; Oka M; Yamamoto M; Shiba M; Uematsu Y; Nishimura Y; Takeshita T; Arita M Am J Hypertens; 2015 Sep; 28(9):1134-40. PubMed ID: 25673039 [TBL] [Abstract][Full Text] [Related]
79. Impaired vagal modulation of heart rate in individuals with Down syndrome. Figueroa A; Collier SR; Baynard T; Giannopoulou I; Goulopoulou S; Fernhall B Clin Auton Res; 2005 Feb; 15(1):45-50. PubMed ID: 15768202 [TBL] [Abstract][Full Text] [Related]
80. GABAergic hyperinnervation of dentate granule cells in the Ts65Dn mouse model of down syndrome: Exploring the role of App. Mojabi FS; Fahimi A; Moghadam S; Moghadam S; Windy McNerneny M; Ponnusamy R; Kleschevnikov A; Mobley WC; Salehi A Hippocampus; 2016 Dec; 26(12):1641-1654. PubMed ID: 27701794 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]